×
Viatris Inventory 2010-2024 | VTRS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Viatris inventory for the quarter ending December 31, 2024 was
$3.854B
, a
11.08% increase
year-over-year.
Viatris inventory for 2024 was
$3.854B
, a
11.08% increase
from 2023.
Viatris inventory for 2023 was
$3.47B
, a
1.41% decline
from 2022.
Viatris inventory for 2022 was
$3.52B
, a
11.52% decline
from 2021.
View More
Viatris Inventory 2010-2024 | VTRS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Viatris inventory for 2024 was
$3.854B
, a
11.08% increase
from 2023.
Viatris inventory for 2023 was
$3.47B
, a
1.41% decline
from 2022.
Viatris inventory for 2022 was
$3.52B
, a
11.52% decline
from 2021.
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$148.1B
Elevance Health (ELV)
$90.8B
CVS Health (CVS)
$83.7B
Cencora (COR)
$47.6B
DiDi Global (DIDIY)
$23.1B
Natera (NTRA)
$22.8B
ICON (ICLR)
$15.8B
Doximity (DOCS)
$14.3B
BioMerieux (BMXMF)
$14.1B
Revvity (RVTY)
$14B
Solventum (SOLV)
$12.8B
Avantor (AVTR)
$12B
CochLear (CHEOY)
$11.5B
Medpace Holdings (MEDP)
$10.5B
HealthEquity (HQY)
$9.9B
EUROFINS SCIENT (ERFSF)
$9.5B
Sonic Healthcare (SKHHY)
$8.8B
Charles River Laboratories (CRL)
$8.4B
Amplifon S.p.A (AMFPF)
$6.2B
Bausch + Lomb (BLCO)
$5.7B
Organon (OGN)
$3.9B
Sotera Health (SHC)
$3.9B
BrightSpring Health Services (BTSG)
$3.6B
Surgery Partners (SGRY)
$3.3B
GeneDx Holdings (WGS)
$3.1B
Concentras Parent (CON)
$3B
Alignment Healthcare (ALHC)
$2.7B
Teladoc Health (TDOC)
$2.4B
Ardent Health Partners (ARDT)
$2.1B
Progyny (PGNY)
$2B